Skip to main content
Edwards Lifesciences Corporation
Healthcare · Medical Devices
Made on Aug 18, 2026
Price at call $90.81
6-month call Bear -8.0%
Target by Feb 2027 $83.50
Great value below $60.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -8.0% to $83.50
Predicted High $92.50 at 1 month
Predicted Low $83.50 at 6 months
Max Drawdown (predicted) -8.0%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 18, 2026 12:52 am
Bear EW trends lower to $83.50 (-8.0% from $90.81) by Feb 2027. ride-then-fade
ThesisEW trades far above every fair-value anchor but momentum, risk-on regime, and low beta support near-term drift higher before value gravity and TAVR deceleration reassert. Expect modest continued strength into autumn, then a slow fade as the growth-vs-valuation gap gets re-priced.
Invalidated ifA break above $98 on strong TAVR data or a break below $82 on guidance cut would invalidate the gentle-fade path.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $90.81 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 18, 2026 $90.81 at call The anchor — every point below is measured from this price and date.
2 weeks Sep 1, 2026 $86.48–$95.14 typical range · internal point $91.80 ±4.8% 7/10 Risk-on tape, low beta, no near-term catalyst
1 month Sep 18, 2026 $84.53–$97.09 typical range · internal point $92.50 ±6.9% 6/10 Momentum persistence, platform-monopoly narrative intact
2 months Oct 18, 2026 $90.50 -0.3% 5/10 Pre-earnings positioning, TAVR deceleration chatter
3 months Nov 18, 2026 $88.00 -3.1% 4/10 Q3 print reintroduces growth-rate scrutiny
4 months Dec 18, 2026 $86.50 -4.7% 4/10 Year-end profit-taking on extended multiple
5 months Jan 18, 2027 $85.00 -6.4% 3/10 Value gravity pulls toward anchored-PE zone
6 months Feb 18, 2027 $83.50 -8.0% 3/10 Slow drift toward deterministic baseline endpoint

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $80.25 (-11.6%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

0 blocking · 2 degraded · 0 notes — follow the chain top-down (cause → effect).
  • Degraded
    [critical] Revenue is volatile and unreliable — growth projections are speculative
    upstream:valuation-synthesis
  • Degraded
    [critical] Valuation is extremely fragile — almost no scenarios support the current price
    upstream:valuation-synthesis

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$90.81
Composite fair value$31.26
Signal-adjusted fair value$32.13
DCF fair value$26.21
Anchored-PE fair value$44.99
Buy-below (value lens)$60.00
Value net score-71
Value confidence6 / 10
Quality net score+46
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 20.5%  3m 24.0%  6m 26.9%  
Daily σ (realism noise)1.5%
Beta vs S&P 500 1m 0.38  3m 0.38  5m 0.53  
Trailing 6-month return19.7%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 18, 2026 freshest EW-20260818-001906-95dd
ext-forensic-memo Aug 18, 2026 freshest ext-EW-20260818-003901-4b17
ext-lens-quality Aug 18, 2026 freshest ext-EW-20260818-003901-4b17
ext-lens-sentiment Aug 18, 2026 freshest ext-EW-20260818-003901-4b17
ext-lens-value Aug 18, 2026 freshest ext-EW-20260818-003901-4b17
scenario-valuation Aug 18, 2026 freshest EW-20260818-001906-95dd
valuation-synthesis Aug 18, 2026 freshest EW-20260818-001906-95dd

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 18, 2026 v0.6.0 Bear $90.81 $83.50 -8.0% Feb 2027 viewing
Jul 22, 2026 v0.6.0 Neutral $84.55 $81.50 -3.6% Jan 2027 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.